cirrhosis diagnosis. Furthermore, the posttreatment parameters of the AFP level 1 tolica del Sacro Cuore, Rome, Italy. month after PEI and recurrence of HCC in the same liver segment were also 2 Divisione di Gastroenterologia, IRCCS Casa evaluated. Sollievo della Sofferenza, San Giovanni Rotondo #
Hemobilia following percutaneous ethanol injection for hepatocellular carcinoma in a cirrhotic patient
β Scribed by Ilario De Sio; Luigi Castellano; Maria Calandra
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 332 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0091-2751
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
For "early" hepatocellular carcinoma (HCC), surgery, orthotopic liver transplantation (OLT) and percutaneous ethanol injection (PEI) improve the natural history of the disease. We performed a retrospective study to evaluate the outcome of patients with cirrhosis and early HCC treated by PEI (n = 417
## Background: The age of patients with hepatocellular carcinoma (hcc) has been increasing worldwide. the objective of this study was to assess the efficacy and safety of percutaneous ethanol injection therapy (peit) in elderly patients with hcc. ## Methods: The authors retrospectively analyzed 6
## BACKGROUND. The authors compared the efficacy of percutaneous microwave coagulation therapy (PMCT) and percutaneous ethanol injection therapy (PEIT) in the treatment of patients with cirrhosis and a solitary nodular hepatocellular carcinoma (HCC) Υ 2 cm in greatest dimension. ## METHODS. Of
## Abstract The purpose of this work is to describe our experience with singleβsession percutaneous ethanol injection (PEI) under the guidance of 0.2βT open MRI for hepatocellular carcinomas (HCC) that were not suitable for ablation under ultrasound (US) or computed tomography (CT) guidance. None o